Speci®c Hox genes are implicated in leukemic transformation, and their selective genetic collaboration with TALE homeobox genes, Pbx and Meis, accentuates their oncogenic potential. The molecular mechanisms underlying these coordinate functions, however, have not been characterized. In this study, we demonstrate that HoxA9 requires its Pbx interaction motif as well as its amino terminus to enhance the clonogenic potential of myeloid progenitors in vitro. We further show that HoxA9 forms functional trimeric DNA binding complexes with Pbx and Meis-like proteins on a modi®ed enhancer. DNA binding complexes containing HoxA9 and TALE homeoproteins display cooperative transcriptional activity and are present in leukemic cells. Trimeric complex formation on its own, however, is not sucient for HoxA9-mediated immortalization. Rather, structurefunction analyses demonstrate that domains of HoxA9 which are necessary for cellular transformation are coincident with those required for trimer-mediated transcriptional activation. Furthermore, the amino terminus of HoxA9 provides essential transcriptional eector properties and its requirement for myeloid transformation can be functionally replaced by the VP16 activation domain. These data suggest that biochemical interactions between HoxA9 and TALE homeoproteins mediate cellular transformation in hematopoietic cells, and that their transcriptional activity in higher order DNA binding complexes provides a molecular basis for their collaborative roles in leukemogenesis. Oncogene (2000) 19, 608 ± 616.
Introduction
Hox genes encode homeodomain-containing transcription factors that are critical determinants of axial patterning during embryogenesis (reviewed in Krumlauf, 1994) . Aside from their well-established roles in generating morphological diversity, Hox genes are also implicated in the regulation of hematopoietic cell dierentiation (reviewed in Lawrence et al., 1996; Magli et al., 1997) . The expression pro®les of individual Hox genes, or groups of Hox genes, correlate with particular blood cell lineages or developmental stages of hematopoiesis (Magli et al., 1991 (Magli et al., , 1997 Sauvageau et al., 1994; Lawrence et al., 1996) . In addition, perturbations of Hox gene expression in hematopoietic cells result in distinct phenotypes (Lawrence et al., 1996; Magli et al., 1997) . More recently, abnormalities observed in blood forming organs from mice harboring targeted Hox gene deletions have ®rmly established their physiological role during hematopoiesis (Lawrence et al., 1996; Magli et al., 1997) .
Concordant with their regulatory functions in hematopoietic cells, aberrant expression of Hox genes is also associated with leukemic transformation. In particular, several independent lines of evidence have demonstrated the importance of HoxA9 in leukemogenesis. In a subset of human myeloid leukemias, chromosomal translocations fuse HoxA9 with the nucleoporin gene, NUP98 (Borrow et al., 1996; Nakamura et al., 1996b) . The oncogenicity of resultant NUP98-HOXA9 fusion proteins was directly correlated to their transcriptional regulatory function, which is mediated in part by domains in HOXA9 that confer interaction with DNA binding cofactor Pbx1 (Kasper et al., 1999) , a homeoprotein of the TALE (Three Amino acid Loop Extension) subfamily (BuÈ rglin, 1997) . Genetic association of Hox and TALE homeobox genes in leukemogenesis has also been observed in animal models. For instance, leukemic cells from BXH-2 mouse strains contain frequent proviral insertions in HoxA9 or HoxA7 that are coincident with insertions in Meis1 (Nakamura et al., 1996c) , another TALE homeobox family member (Moskow et al., 1995; BuÈ rglin, 1997) . Moreover, the collaborative function of HoxA9 and Meis1 in leukemic transformation has been directly demonstrated following their retroviral transduction into primary bone marrow cells (Kroon et al., 1998) . Aside from the reported HoxA9 cooperativity with Meis1, HoxB3 and HoxB4 have also been shown to collaborate with Pbx1b to transform Rat-1 cells . The identi®cation of coactivators that accelerate the otherwise long latency of leukemic onset associated with over-expression of individual Hox genes indicates the importance of oncogenic collaboration with partnering genes in Hox-mediated transformation.
The functional relationship between the Hox and TALE homeobox genes is further supported by molecular studies that demonstrate direct biochemical interactions between their protein products. In vitro, a variety of Hox proteins form heterodimeric DNA binding complexes with Pbx as well as with Meis on bipartite sequence elements that contain their cognate sites (Chang et al., 1995 (Chang et al., , 1997 Knoep¯er and Kamps, 1995; Lu et al., 1995; Phelan et al., 1995; Shen et al., 1997; Knoep¯er et al., 1997; Bischof et al., 1998; Mann and Aolter, 1998) . In addition to their interactions with particular Hox proteins, Pbx and Meis are prevalent intracellular partners and associate to control Pbx nuclear localization, and to promote cooperative DNA binding activity (Chang et al., 1997; Mann and Aolter, 1998; Gonzales-Crespo et al., 1998; Berthelsen et al., 1999) . Furthermore, we and others have demonstrated functional trimeric interactions between Hox, Pbx and Meis-like proteins on native Hox enhancers (Berthelsen et al., 1998; Jacobs et al., 1999) . The sum of genetic and biochemical studies, therefore, highlights the critical role of TALE partners in the execution of Hox dependent pathways.
In this report, we investigate the molecular requirements for TALE homeoproteins in HoxA9-mediated immortalization of primary bone marrow cells. We present both biochemical and biological evidence that supports a role for trimeric interactions between Hox and TALE homeoproteins to function as transcriptional mediators of leukemogenesis.
Results

HoxA9 requires its TALE protein interaction motifs to confer enhanced proliferative capacity on primary hematopoietic cells in vitro
To characterize the eects of HoxA9 overexpression in hematopoietic cells, HoxA9 coding sequences ( Figure  1a ) were introduced downstream of the long terminal repeat (LTR) of the murine stem cell virus (MSCV) to direct its high level expression in myeloid progenitors (Hawley et al., 1994) . HoxA9-containing retroviral stocks were used to infect primary bone marrow cells that were enriched for hematopoietic progenitors through 5-¯uorouracil (5-FU) treatment of donor mice (Lavau et al., 1997) . Results of viral transduction were assessed by in vitro colony formation of G418 resistant clonogenic cells in methylcellulose cultures supplemented with GM-CSF, IL-3, IL-6 and Steel factor. The ability of drug resistant progenitors to generate the expected range of colony types was not apparently altered as a result of either MSCV-neo or MSCVHoxA9 transduction. However, cells infected with MSCV-HoxA9 displayed a 5 ± 10% reduction in the number of colonies formed at primary plating which correlated with lower viral titers obtained with this construct when measured in NIH3T3 cells (data not shown).
To evaluate potential dierences and perturbations mediated by HoxA9 over-expression, infected cells were observed through serial re-plating assays (Lavau et al., 1997) . As early as the secondary plating in methylcellulose, HoxA9 infected cells exhibited striking dierences in both the total number of colonies formed, and in their colony morphology, as compared to cells infected with the MSCV-neo parental vector ( Figure  1b ). MSCV-neo colonies appeared as diuse aggregations of approximately 100 cells in a reproducible range of two to ten colonies ( Figure 1b and data not shown). In contrast, the numerous colonies generated from HoxA9-infected progenitors were dense with compact centers and predominantly of the CFU-GM colony type (Figures 1b and 2a) . By tertiary seeding, MSCV- (Figures 1b and 2b) . However, progenitors expressing HoxA9 continued to display a selective proliferative capacity over several generations and could be subsequently propagated as IL-3-dependent suspension lines. As demonstrated by Wright-Giemsa staining of cytospin preparations, suspension lines were composed mainly of cells with primitive morphologies (Figure 2c ) and expressed cellular markers associated with myeloid precursors, such as c-kit, Mac-1 and Gr-1 (data not shown). These data demonstrate that HoxA9 exhibits immortalizing activity and imparts a growth advantage to primary hematopoietic progenitors in vitro that is exempli®ed by their enhanced proliferative potential.
Since previous genetic and biochemical studies have underscored the integral role of TALE family members in the execution of Hox-dependent developmental and oncogenic processes, we examined the potential contribution of biochemical interactions with TALE homeoproteins in HoxA9-mediated immortalization. Western blot analyses demonstrated that Pbx and Meis proteins were expressed in primary bone marrow cells, with Pbx2, Meis1a and Meis1b as the predominant members (DiMartino and Cleary, 2000, unpublished observations) . We generated retroviral constructs encoding HoxA9 proteins that contained mutations in domains previously implicated to mediate interactions with its known cofactors, Pbx and Meis. As schematized in Figure 1a , the DNT HoxA9 truncation mutant lacked a 61 amino acid segment which reportedly constitutes a Meis interaction domain (DNT HoxA9), whereas another mutant contained point mutations in the tryptophan motif required for Hox-Pbx interaction (HoxA9 NWLH ). In contrast to HoxA9, hematopoietic progenitors transduced with either MSCV-DNT HoxA9 or MSCV-HoxA9 NWLH displayed a limited proliferative capacity, similar to the plating pro®le observed in MSCV-neo infected cells (Figure 1b) . Moreover, these eects were not due to inconsistencies in expression since HoxA9 polypeptides were eectively detected by Western blot analysis (Figure 1c ). Therefore, HoxA9-mediated immortalization of hematopoietic cells relies on the presence of both its N-terminal region and tryptophan motif since mutation of either abrogates biological activity.
HoxA9 forms trimeric DNA binding complexes with TALE homeoproteins
The foregoing results suggested an important role for TALE proteins in the regulation of HoxA9 function in hematopoietic cells. One possibility is that TALE partners cooperate with HoxA9 in the same regulatory pathway as transcriptional Hox-Pbx or Hox-Meis dimeric pairs. An alternative scenario is that Hox, Pbx and Meis proteins may participate in higher order molecular interactions to form trimeric DNA binding complexes. To test these possibilities, homeoprotein DNA binding activity was examined on a modi®ed endogenous enhancer that contained consensus sites for all three proteins. This genetically de®ned response element (Hoxb2r4) has recently been shown to rely on combinatorial interactions between Hox and TALE proteins to mediate appropriate HoxB2 developmental expression in vivo (Jacobs et al., 1999) . For the current studies, we modi®ed the Hox consensus site to optimize for paralog group 9 binding activity (i.e.: TGAT to TTAT). The modi®ed Hox response element was then used to examine the formation of DNA binding complexes using reticulocyte lysates programmed with HoxA9, Pbx2 and Meis1a in gel shift analysis.
On the radiolabeled tripartite element, monomeric binding by HoxA9 as well as dimeric binding with HoxA9 and Pbx2 were observed ( Figure 3a , lanes 2 and 6). Weak cooperative DNA binding was exhibited between Pbx2 and Meis1a, however, binding activity for HoxA9-Meis1a dimers was not detected on this DNA site (Figure 3a , lanes 7 and 5). Most notably, a predominance of a slower migrating complex was observed when all three proteins were present ( Figure  3a , lane 8). The prevalence of the slower migrating complex was accompanied by a marked reduction in the amount of monomeric and dimeric binding activity, which indicates that this higher order con®guration is favored ( Figure 3a , lane 8). Moreover, addition of speci®c antibodies directed against each of the input proteins in the binding reactions resulted in the presence of supershifted complexes that contained all three proteins ( Figure 3b , lanes 4 ± 6). In addition, we detected supershifted HoxA9-Pbx2 dimers ( Figure 3b , lanes 4 and 6). Supershift activity, however, was not observed using an isotype control antibody ( Figure 3b , lane 2). Trimeric interactions were further established by creating mutations in speci®c dimerization motifs. An N-terminal deletion of Pbx2, which is de®cient for interaction with Meis, and a HoxA9 tryptophan . Taken together, these observations demonstrate that HoxA9 can assemble into a higher order, trimeric DNA binding complex with TALE homeoproteins, Pbx2 and Meis1a.
DNA binding complexes containing HoxA9 and TALE homeoproteins are present in nuclear extracts from leukemic cell lines
To investigate potential interactions between HoxA9 and TALE homeoproteins in vivo, we performed gel shift analysis on nuclear extracts prepared from the M1 and B112 myeloid leukemia cell lines, and from a representative suspension line produced in our assay, HoxA9.5. Utilizing the modi®ed enhancer element, gel shift analysis with the M1 nuclear extract revealed two complexes that speci®cally bound to the probe ( Figure  4a ). The upper complex, which exhibited a similar migration as the HoxA9-Pbx2-Meis1a complexes in reticulocyte lysates, was almost completely shifted to a higher mobility by the addition of an anti-HoxA9 antibody (a-HoxA9) and with an anti-Pbx antibody that is reactive with Pbx2 as well as with Pbx1a and Pbx3a (a-Pbx) (Figure 4a , compare lanes 3 and 5 with lane 2). Addition of antibodies speci®c for Meis proteins (a-Meis) resulted in a partial shift of the upper and lower complexes (Figure 4a , compare lanes 4 and 2) whereas addition of antiserum that detects Meis and the related Prep1 protein (a-Prep1) caused a partial disruption of both the upper and lower complexes (Figure 4a , compare lanes 6 and 2). Partial eects observed with either the anti-Meis antibody or anti-Prep1 antiserum indicated the presence of these proteins in DNA bound complexes with Pbx and HoxA9, but also revealed that a subset of Meis-like proteins were either ineciently recognized by the antibodies or that other factors were present. In contrast to the M1 cell line which contains retroviral integrations in HoxA9, addition of an anti-HoxA9 antibody to binding reactions with the B112 nuclear extract did not result in an upper shift since this line contains retroviral integrations in HoxA7 and lacks detectable expression of HoxA9 (Nakamura et al., 1996c) .
Gel shift analysis with nuclear extracts from the HoxA9.5 cell line resulted in a single complex that was partially shifted with either anti-HoxA9, anti-Pbx and anti-Meis antibodies and was accompanied by the appearance of slower migrating complexes of possible dimeric interactions (Figure 4b , compare lane 2 with lanes 3 ± 5 lower arrow). Similar to results obtained with M1 nuclear extracts, partial disruption of the HoxA9.5 complex was observed with the anti-Prep-1 antiserum (Figure 4b , lane 6). In addition to speci®c recognition of homeoprotein complexes containing HoxA9, Meis and Pbx in these cells, a non-speci®c stability eect was observed as evidenced by an increase in band intensities upon antibody addition. Furthermore, DNA bound complexes that contained HoxA9, Meis and Pbx proteins were also detected in clonogenic cell lines, such as FDC-P1, and in primary hematopoietic precursors (data not shown), which is consistent with a potential role for this trimeric complex in early hematopoietic development as well as in leukemogenesis. These results demonstrate that The N-terminus of HoxA9 is necessary for transcriptional activation but is not required for trimeric complex formation
Since our results from the myeloid re-plating assay demonstrated the importance of the N-terminus and tryptophan motif of HoxA9 for its immortalizing activity, we examined the DNA binding properties of HoxA9 mutants using reticulocyte lysates in gel shift analysis. Our rationale was that speci®c mutations in HoxA9 domains that are necessary for reported dimerizations with cofactors Pbx and Meis might also be critical for trimeric interactions and, therefore, may explain the abrogation of biological activity observed in the myeloid assay. On the modi®ed enhancer, monomeric binding activity by HoxA9, HoxA9 NWLH and DNT HoxA9 was observed (Figure 5a , lanes 2 ± 4). As expected, both HoxA9 and DNT HoxA9 exhibited dimeric binding activity with Pbx2, however, dimeric binding was not detected with the tryptophan mutant, HoxA9 NWLH (Figure 5a, lanes 5 ± 7) . Intriguingly, inspection of trimeric binding activity revealed that DNT HoxA9, like HoxA9, formed a higher order complex with Pbx2 and Meis1a, whereas trimeric interactions with HoxA9 NWLH were no longer observed (Figure 5a, lanes 8 ± 10) . Therefore, the N-terminal portion of HoxA9, which was previously shown to mediate dimeric interactions with Meis proteins, was not required for trimeric complex formation on this DNA site.
In order to assess the functional consequences of trimeric HoxA9/Pbx2/Meis1a interactions, transient transcriptional assays were performed. For these studies, a reporter gene that contained two copies of the modi®ed enhancer situated upstream of the SV40 promoter was used in P19 cells, which are permissive for Hox transcriptional activity. Co-transfection of expression constructs containing Pbx2 and Meis1a displayed minimal activation above background (Figure 5b, lane 1) . Reporter gene activity in the presence of HoxA9 alone, or with HoxA9 and Pbx2, was activated approximately ®vefold, indicating that HoxA9 exhibits inherent transcriptional activity that is not apparently altered in the presence of Pbx2 (Figure 5b, lanes 2 and 3) . However, co-transfection of HoxA9, Pbx2 and Meis1a expression plasmids resulted in a 16-fold activation above background levels and approximately threefold above levels observed with HoxA9 and Pbx2 (Figure 5b, lane 4) . Trimer-enhanced transcriptional activation required both the N-terminus and tryptophan motif of HoxA9 since deletion of the N-terminus abrogated HoxA9 transcriptional activity in all contexts and mutation of the tryptophan resulted in comparable reporter gene activity as that observed with HoxA9 alone (Figure 5b , lanes 5 ± 10). Moreover, appropriate levels of protein expression for each of the constructs in P19 cells were veri®ed by Western blot analysis (data not shown). Therefore, these data reveal that trimeric interactions between HoxA9, Pbx2 and Meis1a function to promote heightened transcriptional activation, and highlight the particularly critical role of HoxA9 in trimeric transcriptional activity.
The N-terminus of HoxA9 can be functionally replaced by the VP16 activation domain
The preceding results suggested that trimer enhanced transcriptional activation, as opposed to trimeric complex formation per se, may be an important feature of HoxA9 oncogenic activity in myeloid progenitors. In particular, the HoxA9 N-terminal deletion mutant (DNT HoxA9) retained its ability to form a trimeric DNA binding complex with Pbx2 and Meis1a, but no longer exhibited transforming eects or transcriptional activation. The requirement for HoxA9-mediated transcriptional competence was further investigated using a HoxA9 mutant protein in which an N-terminal segment of HoxA9 was replaced with the herpes simplex virus VP16 transactivation domain ( Figure  1a ). Analogous to HoxA9, myeloid progenitors expressing VP16-HoxA9 exhibited a markedly enhanced plating capacity in methylcellulose over several generations (Figure 1b) , and could also be propagated as IL-3 dependent suspension lines. Thus, a chimeric HoxA9 protein which contains a heterologous transactivation domain, as well as Pbx interaction and DNA binding motifs, immortalizes primary bone marrow cells in vitro with comparable eciency as HoxA9.
The molecular properties of the VP16-HoxA9 fusion protein were further investigated in DNA binding and reporter gene assays. Using gel shift analyses, a trimeric DNA binding complex containing VP16-HoxA9, Pbx2 and Meis1a was detected on the In vitro synthesized proteins were subjected to EMSA using a radiolabeled probe consisting of a modi®ed Hoxb2r4 element containing Meis, Pbx and HoxA9 consensus sites (Jacobs et al., 1999) . HoxA8 polypeptides (schematized in Figure 1 (Figure 5c, lane 8) . In general, VP16-HoxA9 exhibited similar properties as HoxA9 in regards to its monomeric and heterodimeric DNA binding activities, with the exception that its ability to participate in trimeric interactions with Pbx2 and Meis1a was slightly less robust than that observed with HoxA9 (Figures 2a and 5c) . In luciferase assays, co-transfection of VP16-HoxA9 with Pbx2 in P19 cells resulted in a modest increase in transcriptional activation as compared to VP16-HoxA9 alone ( Figure  5d ). However, a notable additive eect on transactivation was observed in the presence of VP16-HoxA9, Pbx2 and Meis1a, indicating that accentuated transcriptional activation occurs upon trimeric complex formation (Figure 5d ). Furthermore, trimer-enhanced transcriptional activation was reproducibly observed at varying concentrations of VP16-HoxA9 (Figure 5d ). Therefore, VP16-HoxA9 is functionally similar to HoxA9 in the contexts examined, and further demonstrates a strong correlation between trimer-mediated transcriptional activation and HoxA9 immortalizing eects in hematopoietic progenitors.
Discussion
The studies presented herein build on a growing body of evidence that supports a collaborative role between members of the Hox and TALE homeoprotein families in leukemic transformation. Whereas previous work has demonstrated their pair-wise genetic cooperativity and has revealed the co-localization of these proteins in myeloid cells (Kroon et al., 1998; Krosl et al., 1998; Shen et al., 1999) , our results provide both biochemical and biological evidence which integrates TALE homeoprotein function in HoxA9-mediated transformation. Based on our ®ndings, we propose a model that implicates trimeric complexes containing HoxA9, Pbx2 and Meis1a as transcriptional mediators of leukemogeneis.
Results by Kroon et al. (1998) demonstrate that leukemic transformation by HoxA9 is greatly accelerated when it is coexpressed with Meis1a, but not with Pbx1b. Consistent with their observations, we also observe that HoxA9 displays inherent immortalizing potential when expressed on its own in hematopoietic progenitors. However, although their results suggest that coexpression of HoxA9 and Meis1a is sucient for primary leukemic transformation, our ®ndings using structure-function analysis reveal a critical role for Pbx in this process. Since nuclear localization of Pbx is regulated by interactions with Meis-like proteins (Gonzales-Crespo et al., 1998; Mann and Aolter, 1998; Berthelsen et al., 1999) , the previously described potency of the HoxA9-Meis1a combination may re¯ect increased nuclear retention of endogenous Pbx by exogenous Meis. Our DNA binding studies reveal that Pbx mutations that compromise its interaction with Meis1a also result in the abrogation of trimeric complex formation. Moreover, the lack of trimeric DNA binding observed with the HoxA9 tryptophan mutant correlates with the loss of both its transforming potential and trimer enhanced transcriptional activity. Consistent with the observations that Pbx utilizes distinct domains to interact with either Hox or Meislike proteins (Chang et al., 1995 (Chang et al., , 1997 Knoep¯er and Kamps, 1995; Phelan et al., 1995; Knoep¯er et al., 1997; Mann and Aolter, 1998; Piper et al., 1999) , our results implicate a role for Pbx as a`bridging factor' between HoxA9 and Meis1a based on a trimeric model. Since endogenous target genes for HoxA9 have not been described, our results on the modi®ed enhancer cannot rule out the possibility of functional Hox-Pbx or Hox-Meis heterodimers in HoxA9-mediated transformation. However, presently, no transcriptional function has been ascribed to Hox-Meis heterodimers (Shen et al., 1997) . In addition, colocalization of HoxA9, Pbx2 and Meis1a to nuclear sites of active transcription in myeloid cells further supports a trimeric function between these homeoproteins (Shen et al., 1999) .
We demonstrate that an N-terminal truncation mutant of HoxA9 no longer exhibits transforming activity in our myeloid assay. This amino terminal region has previously been reported to mediate HoxA9 dimeric interactions with Meis1 proteins (Shen et al., 1997) . Although we were unable to detect HoxA9-Meis1a dimeric binding activity in our studies, this may re¯ect a more rigid spacing requirement by this protein pair since the Meis site is distal to the Pbx/Hox consensus sequences in the modi®ed enhancer. However, our studies show that trimeric complex formation between HoxA9, Pbx2 and Meis1a does not require the N-terminus of HoxA9. Moreover, since trimeric complex formation is abrogated in the presence of HoxA9 NWLH , we surmise that HoxA9 contacts the Pbx-Meis dimer predominantly, if not solely, through interaction with Pbx2 in the DNA context we examined. We provide an explanation for the inability of DNT HoxA9 to transform cells by demonstrating that this domain of HoxA9 is important for trimeric transcriptional activity. These observations suggest that interaction of HoxA9 with Pbx and Meis dictates the transcriptional properties of the trimeric complex perhaps by interacting with other cofactors or with components of the basal transcriptional machinery through this N-terminal region. Indeed, our results with the VP16-HoxA9 fusion protein provide further support that HoxA9-mediated transactivation is an important facet of its transforming potential since a heterologous transactivation domain can functionally replace that of HoxA9. Although cooperative transcriptional activity in regards to the trimeric complex was less accentuated with VP16-HoxA9 as compared to that observed with HoxA9, these eects may be related to dierences in protein structure requirements. Aside from aecting DNA binding preferences, recruitment of potential coactivator and adaptor complexes by the acidic VP16 activation domain may be distinct from those utilized by the alanine-rich HoxA9 N-terminal domain, but nevertheless fully sucient for myeloid transformation.
In addition to its transcriptional properties as a trimeric complex with TALE cofactors, we also observed that monomeric HoxA9 functioned as a modest transcriptional activator. Thus, a similar scenario can be envisioned for HoxA9 as that demonstrated for the pancreatic homeodomain protein, PDX1, wherein cellular context regulates PDX1 function as either a monomeric transcriptional activator or in a trimeric complex with Pbx1b and Meis2 (Swift et al., 1998) . However, our structure-function analyses clearly indicate that the ability of HoxA9 to immortalize primary myeloid progenitors is dependent on TALE cofactor interactions and not a feature of monomeric transcriptional activity.
Aside from these data, we and others have previously reported heterotrimeric interactions between Hox and TALE homeoproteins on various DNA elements (Berthelsen et al., 1998; Jacobs et al., 1999; Shen et al., 1999) . In agreement with our observations, Shen et al. (1999) have also detected the formation of trimeric complexes containing HoxA9, Pbx2 and Meis1a in myeloid cells. However, they demonstrate the ability of trimeric complexes to form on a dimeric Pbx-Hox binding site, where the Meis component is tethered onto the complex. In our DNA binding studies, we did observe weak trimeric interactions upon mutation of the Meis consensus sequence in the tripartite binding element, which was accompanied by an increase in HoxA9-Pbx2 dimeric binding as well as HoxA9 monomeric binding (data not shown). Consistently, however, optimal binding activity by the trimeric complex was dependent on the presence of the Meis site, which suggests that DNA recognition by Meis makes some contribution to the binding requirements of the trimeric complex. The disparity in our ®ndings raises the possibility that the DNA binding requirements for trimeric complex formation may rely on enhancer context or cellular conditions. In summary, these studies demonstrate functional interactions between Hox and TALE homeoproteins and provide a molecular basis for their collaborative functions in cellular transformation. Our observations suggest the possibility that perturbations in the regulated balance of these important transcription factors in hematopoietic cells contributes to inappropriate gene expression, which ultimately promotes leukemic transformation. In future work, it will be interesting to examine the intimate relationship between Hox and TALE homeoproteins in regards to their chimeric counterparts, E2A-Pbx1 and NUP98-HoxA9.
Materials and methods
DNA constructs and cell lines
cDNA sequences encoding murine HoxA9 were cloned in frame with those corresponding to a FLAG epitope by standard PCR methods into the BamHI and EcoRI sites of the in vitro transcription vector pSP64 (Stratagene). fHoxA9 coding sequences were inserted by blunt end ligation into the EcoRI site of pMSCV and into the BglII site of pCMV for retroviral and mammalian expression, respectively. Truncated and mutated forms of HoxA9 were created by PCR mutagenesis using oligonucleotides that contained EcoRI and XhoI restriction sequences for directional insertion into the corresponding sites of pMSCV and pSP73 (Stratagene). Identical sequences encoding HoxA9 mutants were subcloned by blunt end ligation into the SmaI site of pCMV. HoxA9 coding sequences were inserted downstream and in frame with those encoding the maltose binding protein by standard cloning procedures. Plasmids containing Meis1a and Pbx2 coding sequences in pSP and pCMV have been described previously (Monica et al., 1991; Chang et al., 1997) . The Nterminal Pbx2 deletion mutant was generated by PCR mutagenesis using oligonucleotides that contained ClaI and XbaI sites was inserted into the corresponding sites of pSP73. The luciferase reporter construct was created by blunt end ligation of an oligonucleotide that contained two copies of a modi®ed Hoxb2r4 enhancer element into the BglII site of the pGL3 vector (Promega). The pSP HA-VP16-HoxA9 fusion construct was generously provided by J van Deursen and generated as described previously (Kasper et al., 1999) . VP16-HoxA9 sequences were subcloned into pMSCV and pCMV by blunt end ligation using standard cloning procedures. The M1 and B112 myeloid leukemia cells lines (Nakamura et al., 1996a,c) were kind gifts of N Copeland.
Retroviral stocks and methylcellulose assays
The production of retroviral supernatants was conducted as previously described (Pear et al., 1993) using the FNX packaging cell line (a gift of G Nolan). Infection of primitive hematopoietic progenitors and their culture in methylcellulose were performed as previously described (Lavau et al., 1997) . Brie¯y, bone marrow cells were harvested from C57BL/6 mice treated 5 days prior with 5-¯uorouracil (5-FU). Harvested cells were cultured overnight with IL-3 (10 ng/ ml), IL-6 (10 ng/ml), and stem cell factor (SCF) (100 ng/ml). The cells were infected twice by spinoculation for 90 min each at 328C. Following the second spinoculation, 2 ± 3610 3 cells were seeded in Methocult M3230 methylcellulose medium (Stem Cell Technologies Inc.) supplemented with cytokines (10 ng/ml each IL-3, IL-6, GM-CSF; 100 ng/ml SCF) with or without 1.3 mg of G418 per ml. Comparable titers of retroviral stocks were con®rmed by performing parallel titrations in NIH3T3 cells. Growth of cells transduced with the dierent constructs was assessed during the course of serial methylcellulose cultures by scoring the number of colonies and recording their morphology.
Electrophoretic mobility shift assays
DNA binding assays employed proteins that were either produced in vitro from pSP6 expression plasmids using a coupled reticulocyte lysate system according to manufacturer's instructions (Promega), or from nuclear extracts of cultured cell lines as described previously (Chang et al., 1997) . DNA binding reactions were performed at 48C for 30 min in a 15 ml reaction under conditions reported previously (Chang et al., 1997) and subjected to EMSA using 6% polyacrylamide gels in 0.256Tris-borate-EDTA (TBE) buer. DNA probes consisted of gel-puri®ed, endlabeled, double stranded oligonucleotides encoding a modi®ed form of the Hoxb2r4 enhancer (Maconochie et al., 1997; Jacobs et al., 1999) (5'-GGAGCTGTCAGGGGGCTAA-GATTTATCGCC-3', Meis and Pbx/Hox sites underlined). For supershift analyses, 1 mg of monoclonal antibody was added to the DNA binding reactions.
Transcriptional assays
For transient transcriptional assays, P19 cells were seeded at 10 5 cells per 35 mm dish in Alpha Modi®ed Eagle's Medium containing 2.5% fetal bovine serum, 7.5% calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin 16 ± 24 h prior to transfection. Cells were transfected by a calcium phosphate co-precipitation procedure using dierent combinations of expression plasmids encoding Pbx2 (1 mg), HoxA9 (500 ng), VP16-HoxA9 (1 or 5 ng) or Meis1a (2 mg) along with a reporter (1 mg) and a pCMV-bgal internal control plasmid (1 mg). Total DNA concentrations per dish were kept constant with non-speci®c DNA. Luciferase activity was measured according to manufacturer's instructions (Promega) with a Monolight 2010 luminometer; b-gal activity was measured as previously described (Schnabel and Abate-Shen, 1996) and used to normalize luciferase activity to account for dierences in transfection eciency.
Western blots and antibodies
Western blots were performed as described previously (Schnabel and Abate-Shen, 1996) using commercial anti-FLAG (Sigma) or anti-HA (Boehringer-Mannheim) antibodies, or an anti-HoxA9 monoclonal antibody on whole cell lysates of FNX cells transiently transfected with various HoxA9 retroviral constructs. The anti-HoxA9 antibody, directed against an epitope located in the ®rst 60 N-terminal amino acids, was raised against an MBP-HoxA9 fusion protein using standard techniques. Anti-Meis and anti-Pbx (long form) speci®c antibodies have been reported previously (Chang et al., 1997; Jacobs et al., 1999) . Anti-Prep1 antiserum was obtained commercially (Santa Cruz Biotechnology).
